Chief Scientific Officer

Agnès Bernet is Professor of cancer biology at the University Claude Bernard Lyon I.

Co-founder of NETRIS Pharma, she led within the Laboratory of Apoptosis, Cancer and Development, the research team that validated the use of interference ligand/dependence receptors as novel targeted therapies for oncology.

She was nominated to the “Institut Universitaire de France”, which recognizes the best French academic researchers and has followed a course of entrepreneurship at the Lyon Management School and at Boston Babson College (USA).

She was appointed by the French president to the highest French distinction as Knight of the Legion of Honor.